#USA #Chicago #Genetic Testing #Complete Genomics #Velsera

Partnership Revolutionizing Genetic Testing

Complete Genomics, an innovative leader in genomic sequencing, has officially teamed up with Velsera, a prominent player in global healthcare technology, to introduce a groundbreaking genetic testing solution. This collaboration promises to integrate the advanced DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW), streamlining the process of genetic testing from sample collection to clinical reporting.

The alliance was unveiled recently during the American Association for Cancer Research (AACR) Annual Meeting held in Chicago. With this partnership, both companies aim to accelerate and enhance the accuracy and cost-effectiveness of genetic testing, which is critical for clinical oncology labs and assay developers focused on improving patient care.

The Benefits of the Collaboration

Lisa Weingartner, Head of Global Partnerships at Velsera, emphasized the importance of this collaboration, stating, “This partnership enables clinical laboratories and assay developers to accelerate the path from raw sequencing data to actionable clinical insights.” By merging variant interpretation, tertiary analysis, reporting, and decision support, the unified workflow is expected to provide labs with the tools needed for accurate and consistent genomic testing.

Velsera's platform will facilitate plug-in workflows within the CGW to support straightforward implementation of standardized assays, combining post-secondary and secondary analysis models. In return, Complete Genomics will supply an array of DNBSEQ genetic sequencing solutions alongside advanced lab automation platforms.

Enhancing Laboratory Efficiency

As Rob Tarbox, Vice President of Product and Marketing at Complete Genomics, highlighted, this partnership allows the company to broaden its service offerings for clinical laboratories. “Through our partnership with Velsera, Complete Genomics is expanding our ability to serve clinical laboratories with a truly end-to-end solution from sample to insight.” By synergizing cutting-edge sequencing technology with Velsera’s data analysis capabilities, labs are empowered to deliver superior quality and actionable results with enhanced efficiency and confidence.

Commitment to Innovation

Founded in 2005, Complete Genomics has been a trailblazer in developing effective and economical high-throughput sequencing technologies. Their innovations have contributed to over 10,900 publications across various applications in the realm of life sciences. The company's focus on advancing genomic solutions continues to reshape the landscape of genetic testing.

Velsera, established in 2023 due to the merger of several influential companies in the healthcare tech space, is committed to transforming precision medicine. Their goal is to enable experts in clinical diagnostics to make informed decisions about therapies that are tailored to specific patients at the right time.

With both Complete Genomics and Velsera sharing a vision of leveraging technology to enhance patient outcomes, this partnership marks a significant step forward in making genetic testing more accessible, timely, and effective. As healthcare continues to advance rapidly, collaborations like this pave the way for innovative solutions that can fundamentally change patient care for the better.

In conclusion, the integration of Complete Genomics’ sequencing technology with Velsera’s advanced analytics will set a new standard in the genetic testing arena, ensuring that clinical labs can deliver precise and actionable genomic data, ultimately improving healthcare delivery and patient outcomes worldwide.